Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel Complex/Leucine-Rich, glioma inactivated 1 antibody encephalitis

JAMA Neurology

Volumn 71, Issue 10, 2014, Pages 1300-1304

  Naasan, Georges ^a   Irani, Sarosh R ^a,b   Bettcher, Brianne M ^a   Geschwind, Michael D ^a   Gelfand, Jeffrey M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; ETIRACETAM; IMMUNOGLOBULIN; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY; LORAZEPAM; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX ANTIBODY; AUTOANTIBODY; LGI1 PROTEIN, HUMAN; PROTEIN; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AMNESIA; ANTIBODY TITER; ARTICLE; BRADYCARDIA; CASE REPORT; COGNITIVE DEFECT; COMPULSION; CONFUSION; DELUSION; DIZZINESS; ENCEPHALITIS; EPILEPTIC STATE; EPISODIC MEMORY; FAINTNESS; FATIGUE; FEMALE; HALLUCINATION; HUMAN; HYPONATREMIA; INSULA; MALE; MENTAL INSTABILITY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY HALLUCINATION; PACEMAKER IMPLANTATION; PANIC; PRODROMAL SYMPTOM; RETREATMENT; RETURN TO WORK; SHORT TERM MEMORY; SICK SINUS SYNDROME; SINUS ARREST; TEMPORAL LOBE; TONIC CLONIC SEIZURE; UNCONSCIOUSNESS; VERBAL MEMORY; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY ENCEPHALITIS; ARTIFICIAL HEART PACEMAKER; BRAIN; COMPLICATION; IMMUNOLOGY; NEUROLOGIC DISEASE; PATHOLOGY; SEIZURES;

AMNESIA; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BRADYCARDIA; BRAIN; ENCEPHALITIS; FEMALE; HUMANS; HYPONATREMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POTASSIUM CHANNELS, VOLTAGE-GATED; PRODROMAL SYMPTOMS; PROTEINS; SEIZURES;

EID: 84907977347     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.1234     Document Type: Article

References (21)

1. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62 (7): 1177-1182.
2. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-Associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(Pt 3): 701-712.
3. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol. 2010;9(8): 776-785.
4. Irani SR, Alexander S,Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9): 2734-2748.
5. SamuelsMA. The brain-heart connection. Circulation. 2007;116(1): 77-84.
6. Bettcher BM, Gelfand JM, Irani SR, et al. More than memory impairment in voltage-gated potassium channel complex encephalopathy [published online July 1, 2014]. Eur J Neurol. doi: 10.1111/ene.1248224981998.
7. Irani SR, Gelfand JM, Bettcher BM, et al. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-Associated encephalopathy. JAMA Neurol. 2014;71(7): 896-900.
8. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992;42(9): 1727-1732.
9. Britton JW, Ghearing GR, Benarroch EE, Cascino GD. The ictal bradycardia syndrome: Localization and lateralization. Epilepsia. 2006;47(4): 737-744.
10. Schulte U, Thumfart JO, Klöcker N, et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron. 2006;49(5): 697-706.
11. Irani SR,Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5): 892-900.
12. Lalic T, Pettingill P, Vincent A, Capogna M. Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia. 2011;52(1): 121-131.
13. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci. 2013;33(46): 18161-18174.
14. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50(1): 73-78.
15. Jacob S, Irani SR, Rajabally YA, et al. Hypothermia in VGKC antibody-Associated limbic encephalitis. J Neurol Neurosurg Psychiatry. 2008; 79(2): 202-204.
16. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011; 69(2): 303-311.
17. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: Clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2): 241-255.
18. Wieser S, Kelemen A, Barsi P, et al. Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord. 2005;7(3): 205-211.
19. Lee M, Lawn N, Prentice D, Chan J. Anti-NMDA receptor encephalitis associated with ictal asystole. J Clin Neurosci. 2011;18(12): 1716-1718.
20. Millichap JJ, Goldstein JL, Laux LC, Nordli DR Jr, Stack CV,Wainwright MS. Ictal asystole and anti-N-methyl-D-Aspartate receptor antibody encephalitis. Pediatrics. 2011;127(3): E781-e786.
21. Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain. 2013;136(pt 10): 3151-3162.